NOVARTIS HEALTHCARE PHILIPPINES INC

Novartis Healthcare Philippines Inc. is a trading company.

Enterprise Introduction:

Novartis Healthcare Philippines Inc. serves as the local subsidiary of Novartis AG, a global healthcare company headquartered in Switzerland. Its primary function in the Philippines involves the marketing, sales, and distribution of a comprehensive range of pharmaceutical products. These include innovative medicines, generic drugs through Sandoz, and eye care solutions from Alcon. The company is dedicated to providing access to essential medicines and advanced healthcare solutions for Filipino patients and healthcare professionals. While Novartis maintains manufacturing facilities globally, Novartis Healthcare Philippines Inc. itself operates as the commercial and distribution arm, responsible for the trade, promotion, and regulatory affairs of Novartis products within the Philippine market, rather than being a manufacturing plant. Its mission is to reimagine medicine to improve and extend people's lives in the Philippines.

Novartis Healthcare Philippines Inc. sells and distributes a comprehensive portfolio of pharmaceutical products across various therapeutic areas. These include medicines for cardiovascular, renal and metabolic conditions such as Entresto and Diovan; immunology, hepatology and dermatology treatments like Cosentyx and Xolair; neuroscience products including Gilenya and Exelon; and a range of oncology medicines such as Kisqali, Tafinlar + Mekinist, and Promacta/Revolade. The company also provides respiratory and ophthalmology treatments. Furthermore, through its Sandoz division, it offers a wide array of generic pharmaceuticals and biosimilars covering anti-infectives, cardiovascular, central nervous system, and pain relief categories.